Benjamin Lee, MD
Urology · Tucson, AZNPI 1013087451
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,000 of the $8,067 with a category attached, or 62.0%. Intuitive Surgical accounts for 77.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $6,315 and has fallen 91.9% since, to $515 in 2025.
Across 15 payments — averaging $537.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Pharmaceutical Business Consultants Limited$1K
- Mochida Pharmaceutical CO., LTD$500
- Astellas Pharma US Inc$70
- Boston Scientific$26
- Johnson & Johnson$15
- plus $12 from 1 others
Across 2 payments — averaging $14,125 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ferring Pharmaceuticals AS$28K
What the payments were for
- Consulting fees$5006%
- Speaking & faculty fees$5,00062%
- Travel & lodging$1,24515%
- Food & beverage$1101%
- Education$120%
- Charitable contribution$1,20015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $6,245 |
| Pharmaceutical Business Consultants Limited | 2 | $1,200 |
| Mochida Pharmaceutical CO., LTD | 1 | $500 |
| Astellas Pharma US Inc | 1 | $70 |
| Boston Scientific | 1 | $26 |
| Johnson & Johnson | 1 | $15 |
| Urogen Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,058
- ReFeel$500
How this compares
$8,067 in reported general payments places this provider in the 70th percentile of 269 urology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 14 | $143 |
| Levofloxacin | 24 | $49 |
Paid to pharmacies, not to this prescriber.
Other urology in Tucson
- Mitzi BarmatzTucson$135K
- Curtis DunsheeTucson$46K
- Susan KalotaTucson$30K
- Kalpesh PatelTucson$26K
- Tristan BerryTucson$14K
- Aleksandar BlubaumTucson$11K
- Mitchell HumphreysPhoenix$358K
- Shawn BlickGoodyear$336K
- Daniel JaffeePhoenix$280K
- Rahul MehanMesa$277K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.